The short answer
High-dose niacin used to change cholesterol levels can increase muscle-toxicity risk with atorvastatin. The concern is chiefly lipid-modifying nicotinic acid, generally at least 1 gram daily, rather than an automatic warning against every nutritional vitamin B3 dose.
What this answer covers
Oral atorvastatin with niacin-containing products. Nicotinic acid, niacinamide and nutritional amounts require distinct interpretation.
- Supplement or preparation
- niacin
- Medication ingredient
- atorvastatin
Which niacin products matter?
Check both the chemical form and total daily amount. Vitamin B3 products can contain nicotinic acid, nicotinamide or other derivatives, and high-strength bottles may deliver drug-like doses. They are not interchangeable for either cholesterol effects or adverse effects.
What does the evidence show?
A twelve-week study included atorvastatin with extended-release niacin and reported no drug-related muscle or liver toxicity. That is useful neutral evidence, but the trial was too short and limited to exclude rare harm. It also did not include a matching atorvastatin-alone arm.
What does current prescribing advice say?
LIPITOR describes muscle injury with lipid-modifying niacin and calls for a benefit-risk assessment and monitoring if used together. A favorable short trial does not erase that warning. Prescribed combined therapy can be assessed individually; it should not be started as unsupervised supplementation.
Does this mean I need more B3 or a timing gap?
No increased nutritional requirement or protective separation interval is established by these findings. Bring the bottle and reason for use to your pharmacist. Report unexplained muscle symptoms promptly, and let the prescriber decide whether either treatment should change.
Evidence and practical considerations
Side effects & toxicity
High-dose niacin used to change cholesterol levels can increase muscle-toxicity risk with atorvastatin. The concern is chiefly lipid-modifying nicotinic acid, generally at least 1 gram daily, rather than an automatic warning against every nutritional vitamin B3 dose.
- Exact scope
- Oral atorvastatin with niacin-containing products. Nicotinic acid, niacinamide and nutritional amounts require distinct interpretation. with Exact RxNorm 83367, IN, atorvastatin. LIPITOR contains atorvastatin calcium trihydrate, with strength expressed as atorvastatin active moiety in the label. This is the explicit salt-to-IN bridge.
- Medication form and route
- oral
What remains uncertain
- Evidence concerns pharmacologic nicotinic acid. No proven depletion, extra B3 requirement or protective spacing interval. Trial formulation and population limits apply.
Factors that may matter: Exact preparation, dose, other medicines and baseline clinical condition matter..
Read the supporting source summaries
Source 1: regulatory prescribing information
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: People prescribed oral atorvastatin.
Provides grapefruit and lipid-modifying niacin precautions, symptom monitoring and once-daily administration with or without food.
How this applies: Restricted to the exact identities and conditions described in this article.
Absence of an ingredient from the label is not a negative interaction study. No pectin, oat bran or Panax-specific human effect size is supplied.
Source 2: government nutrient reference
ods.od.nih.gov · Source check Sep 10, 2026
Population: People consuming nutritional or pharmacologic forms of vitamin B3.
Lipid-modifying nicotinic acid and nutritional B3 exposure are not interchangeable. Some supplements contain high doses.
How this applies: Restricted to the exact identities and conditions described in this article.
General nutrient guidance does not quantify a statin-specific interaction risk for every form.
Source 3: original human study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: 292 participants randomized across four open-label treatment arms.
Reported no drug-related myopathy or hepatotoxicity in this short trial.
How this applies: Restricted to the exact identities and conditions described in this article.
No matched atorvastatin-alone comparison; a limited trial cannot exclude rare toxicity or establish cardiovascular benefit from adding niacin.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Original-source assessment and consumer article prepared; exact claim dispositions, neutral findings and preparation limits recorded. | |
| Clinical sign-off is pending and no publication approval is asserted. | |
| Research summary published |
Article revision: e036941dcde439e5
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.